The Frequency of Peripheral Arterial Disease in Patients with Deep Vein Thrombosis of the Lower Limbs

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorIRCCS Azienda Ospedaliero-Universitaria di Bologna

About this trial

The aim of the study is to assess the frequency of Peripheral Arterial Disease (PAD) and cardiovascular risk factors in patients with unprovoked Deep Vein Thrombosis (DVT) of the lower limbs, comparing them with patients who have provoked DVT or cancer-related DVT. Additionally, the study aims to examine the association between the Ankle-Brachial Index (ABI) and Carotid Intima-Media Thickness (IMT) in the different patient groups.

This is an observational, spontaneous, monocentric, non-pharmacological study conducted on outpatient, non-hospitalized patients diagnosed with lower limb DVT, including both unprovoked and provoked DVT, as well as cancer-related DVT. The patients are followed at the Vascular Day Service of the SSD U.O. Angiology and Coagulation Disorders Unit at the Sant'Orsola Malpighi Polyclinic in Bologna. The study has a retrospective design for patients with DVT diagnosed between October 1, 2020, and the date of project approval, and a prospective design for patients diagnosed with DVT after this date. The study is expected to conclude by December 31, 2027.

Eligibility criteria

Qualifiers

Age > 18 years

Diagnosis of unprovoked, provoked, or cancer-related DVT

Diagnosis of DVT in the lower limbs, both proximal and distal, subjected to compression ultrasound within 6 months of diagnosis

Ability to provide informed consent

Disqualifiers

Diagnosis of upper limb DVT or DVT in other locations, if not concurrent with lower limb DVT

Diagnosis of superficial venous thrombosis (SVT), if not concurrent with lower limb DVT

Diagnosis of DVT associated with central venous catheters (CVC)

Presence of epithelial or basal cell carcinomas, as they are associated with a low risk of deep vein thrombosis

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

No trial groups listed